(Total Views: 473)
Posted On: 06/17/2019 2:10:44 PM
Post# of 71

$ARNA News Article - Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis https://marketwirenews.com/news-releases/aren...68246.html


My Twitter: WhyteStocks